+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Structural Heart Imaging Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163340
The global structural heart imaging market was valued at USD 17.40 Billion in 2024, driven by increasing incidence of cardiovascular conditions across the globe. The market is expected to grow at a CAGR of 10.11% during the forecast period of 2025-2034, with the values likely to reach USD 45.58 Billion by 2034.

Global Structural Heart Imaging Market Overview

Structural heart imaging involves using medical imaging techniques and modalities to analyze the functionality, anatomy, and pathology of the heart. Cardiovascular diseases pose a major burden with the mortality rate reaching 19.8 million in 2022. It is estimated that each year, around 60 million people worldwide develop a heart or circulatory disease, with 1 in 13 people affected by one circulatory or heart disease. The market growth is driven by increasing preference for minimally invasive procedures, technological advancements in echocardiography, computed tomography (CT) and cardiac magnetic resonance imaging (MRI) among others.

Global Structural Heart Imaging Market Growth Drivers

Increasing Prevalence of Cardiovascular Diseases to Affect the Market Landscape Significantly

With rising incidence of cardiovascular conditions, the market has been witnessing an influx of new and innovative products to provide enhanced patient outcomes. In October 2023, ConcertAI's TeraRecon integrated generative artificial intelligence to support clinical research and offer advanced visualization for improved patient outcomes. The company is also launching a multi modal AI platform to support the same. The market growth is heavily influenced by the rising integration of artificial intelligence and machine learning in the existing imaging facilities.

Growth in Strategic Partnerships and Mergers to Meet Rising Structural Heart Imaging Market Demand

In May 2023, Stereotaxis and Abbott collaborated to offer precise and stable diagnostic facilities for procedural workflow and enhance patient experience. Using Abbott's cardiac mapping system and Stereotaxis' advanced robotic technology, the partnership highlights an emphasis on robotic incorporation into the healthcare ecosystem. Robotic Magnetic Navigation uses computer-controlled magnetic fields for direct control of a catheter tip, leading to enhanced stability, precision, and safety.

Global Structural Heart Imaging Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Rising Demand for Minimally Invasive Procedures

To mitigate the complications associated with traditional open-heart surgeries, minimally invasive procedures are garnering popularity. The benefits including shorter recovery time span, lower complication risk and procedural accuracy contribute to its wide application in the market.

Shift Towards Personalized Medicine

In order to manage and treat cardiovascular conditions more effectively, personalized medicine involving a set of diverse pharmacological and interventional therapies is one of the major market trends.

Preference for 3D and 4D Imaging Technologies

The development of 3D and 4D imaging techniques facilitates healthcare providers with detailed anatomical and functional information. 4D imaging technologies enhance the three-dimensional volumetric data with the help of visualization software and allows clinicians to analyze complex cardiac data efficiently.

Emphasis on Value Based Care

Increasing incidence of cardiovascular diseases, owing to evolving lifestyle and dietary habits has led to growing focus on optimized treatment planning, precise and early diagnosis, along with controlled costs. The global healthcare ecosystem is driven towards value-based care models that prioritize improving patient outcomes with the help of awareness programs and improvement in patient outcomes.

Global Structural Heart Imaging Market Segmentation

Structural Heart Imaging Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Imaging Modality

  • Echocardiography (2D and 3D)
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Angiography (including Transesophageal Echocardiography)
  • Nuclear Imaging
  • Others

Market Breakup by Application

  • Valvular Heart Disease
  • Congenital Heart Disease
  • Cardiomyopathy
  • Others

Market Breakup by Technology

  • 2D Imaging
  • 3D Imaging
  • 4D Imaging
  • Doppler Imaging
  • Contrast Imaging

Market Breakup by Test Type

  • Stress Testing
  • Transthoracic Echocardiogram (TTE)
  • Transesophageal Echocardiogram (TEE)
  • Cardiac Catheterization
  • Others

Market Breakup by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Structural Heart Imaging Market Share

Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth

Based on application, the market segmentation includes valvular heart disease, congenital heart disease and cardiomyopathy among other applications. Rising prevalence of unhealthy dietary habits and sedentary lifestyle are contributing to growth in cardiovascular conditions, which is further impacting the structural heart imaging market value significantly. Valvular heart diseases involve abnormalities with the heart valve and structural imaging plays a vital role in analyzing the suitable treatment for the condition.

3D and 4D Imaging Technologies Expected to Lead the Market Share

Based on technology, the market constitutes 2D imaging, 3D imaging, 4D imaging, doppler imaging and contrast imaging. 3D and 4D imaging technologies are gaining high popularity. 3D echocardiography is one of the most commonly used 3D imaging techniques which leverages specialized transducers and advanced software algorithms to reconstruct three-dimensional images of the heart. Similarly, 4D echocardiography captures the volumetric data of beating heart to evaluate valve function and ventricular volumes. To enhance the quality of diagnosis and therapeutic capabilities, healthcare providers may use multiple imaging technologies in image processing.

Global Structural Heart Imaging Market Analysis by Region

Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America and Europe, having a robust healthcare infrastructure and prominent healthcare companies at home, is estimated to hold a high market value. Increasing collaborations between academic institutions and MedTech organizations to boost research initiatives also fuel the region's market share.

Asia Pacific is projected to witness substantial growth. It can be accredited to increased expenditure to improve the healthcare infrastructure and cater to diverse patient demands. Owing to the presence of skilled healthcare practitioners, affordable procedures and personalized care, countries like India, and South Korea are experiencing surge in medical tourism. Consequently, they are likely to emerge as one of the major treatment hubs in the region.

Leading Players in the Global Structural Heart Imaging Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • General Electric Company (GE Healthcare)
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Hitachi, Ltd.
  • Shimadzu Corporation
  • Esaote S.p.A.
  • FUJIFILM Holdings Corporation
  • Samsung Medison Co., Ltd.
  • Carestream Health, Inc.
  • Toshiba Corporation (Canon Medical Systems)
  • Mindray Medical International Limited
  • Pie Medical Imaging
  • 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging)
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in the Global Structural Heart Imaging Market Report

  • What was the global structural heart imaging market value in 2023?
  • What is the global structural heart imaging market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is market segmentation based on imaging modalities?
  • What is the market breakup based on test types?
  • Who are the major end users in the market?
  • What type of technologies are present in the market?
  • Where does structural heart imaging find its application?
  • What are the major factors aiding the global structural heart imaging market demand?
  • How has the structural heart imaging market performed so far and how is it anticipated to perform in the coming years?
  • What are the major market trends influencing the market?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
  • What are the major global structural heart imaging market trends?
  • How does the rise in the geriatric population impact the market size?
  • What imaging modality will dominate the market share?
  • Which application area is expected to have a high market value in the coming years?
  • Which technology type will experience the highest demand in the market segment?
  • Who are the key players involved in the structural heart imaging market?
  • What is patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Structural Heart Imaging Market Overview
3.1 Global Structural Heart Imaging Market Historical Value (2018-2024)
3.2 Global Structural Heart Imaging Market Forecast Value (2025-2034)
4 Global Structural Heart Imaging Market Landscape*
4.1 Global Structural Heart Imaging: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Structural Heart Imaging: Product Landscape
4.2.1 Analysis by Imaging Modality
4.2.2 Analysis by Application
5 Global Structural Heart Imaging Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Structural Heart Imaging Market Segmentation (2018-2034)
6.1 Global Structural Heart Imaging Market (2018-2034) by Imaging Modality
6.1.1 Market Overview
6.1.2 Echocardiography (2D and 3D)
6.1.3 Magnetic Resonance Imaging (MRI)
6.1.4 Computed Tomography (CT)
6.1.5 Angiography (including Transesophageal Echocardiography)
6.1.6 Nuclear Imaging
6.1.7 Others
6.2 Global Structural Heart Imaging Market (2018-2034) by Application
6.2.1 Market Overview
6.2.2 Valvular Heart Disease
6.2.3 Congenital Heart Disease
6.2.4 Cardiomyopathy
6.2.5 Others
6.3 Global Structural Heart Imaging Market (2018-2034) by Technology
6.3.1 Market Overview
6.3.2 2D Imaging
6.3.3 3D Imaging
6.3.4 4D Imaging
6.3.5 Doppler Imaging
6.3.6 Contrast Imaging
6.4 Global Structural Heart Imaging Market (2018-2034) by Test Type
6.4.1 Market Overview
6.4.2 Stress Testing
6.4.3 Transthoracic Echocardiogram (TTE)
6.4.4 Transesophageal Echocardiogram (TEE)
6.4.5 Cardiac Catheterization
6.4.6 Others
6.5 Global Structural Heart Imaging Market (2018-2034) by End User
6.5.1 Hospitals
6.5.2 Diagnostic Imaging Centers
6.5.3 Ambulatory Surgical Centers
6.5.4 Others
6.6 Global Structural Heart Imaging Market (2018-2034) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Structural Heart Imaging Market (2018-2034)
7.1 North America Structural Heart Imaging Market (2018-2034) by Imaging Modality
7.1.1 Market Overview
7.1.2 Echocardiography (2D and 3D)
7.1.3 Magnetic Resonance Imaging (MRI)
7.1.4 Computed Tomography (CT)
7.1.5 Angiography (including Transesophageal Echocardiography)
7.1.6 Nuclear Imaging
7.1.7 Others
7.2 North America Structural Heart Imaging Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Valvular Heart Disease
7.2.3 Congenital Heart Disease
7.2.4 Cardiomyopathy
7.2.5 Others
7.3 North America Structural Heart Imaging Market (2018-2034) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Structural Heart Imaging Market (2018-2034)
8.1 Europe Structural Heart Imaging Market (2018-2034) by Imaging Modality
8.1.1 Market Overview
8.1.2 Echocardiography (2D and 3D)
8.1.3 Magnetic Resonance Imaging (MRI)
8.1.4 Computed Tomography (CT)
8.1.5 Angiography (including Transesophageal Echocardiography)
8.1.6 Nuclear Imaging
8.1.7 Others
8.2 Europe Structural Heart Imaging Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Valvular Heart Disease
8.2.3 Congenital Heart Disease
8.2.4 Cardiomyopathy
8.2.5 Others
8.3 Europe Structural Heart Imaging Market (2018-2034) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Structural Heart Imaging Market (2018-2034)
9.1 Asia Pacific Structural Heart Imaging Market (2018-2034) by Imaging Modality
9.1.1 Market Overview
9.1.2 Echocardiography (2D and 3D)
9.1.3 Magnetic Resonance Imaging (MRI)
9.1.4 Computed Tomography (CT)
9.1.5 Angiography (including Transesophageal Echocardiography)
9.1.6 Nuclear Imaging
9.1.7 Others
9.2 Asia Pacific Structural Heart Imaging Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Valvular Heart Disease
9.2.3 Congenital Heart Disease
9.2.4 Cardiomyopathy
9.2.5 Others
9.3 Asia Pacific Structural Heart Imaging Market (2018-2034) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Structural Heart Imaging Market (2018-2034)
10.1 Latin America Structural Heart Imaging Market (2018-2034) by Imaging Modality
10.1.1 Market Overview
10.1.2 Echocardiography (2D and 3D)
10.1.3 Magnetic Resonance Imaging (MRI)
10.1.4 Computed Tomography (CT)
10.1.5 Angiography (including Transesophageal Echocardiography)
10.1.6 Nuclear Imaging
10.1.7 Others
10.2 Latin America Structural Heart Imaging Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Valvular Heart Disease
10.2.3 Congenital Heart Disease
10.2.4 Cardiomyopathy
10.2.5 Others
10.3 Latin America Structural Heart Imaging Market (2018-2034) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Structural Heart Imaging Market (2018-2034)
11.1 Middle East and Africa Structural Heart Imaging Market (2018-2034) by Imaging Modality
11.1.1 Market Overview
11.1.2 Echocardiography (2D and 3D)
11.1.3 Magnetic Resonance Imaging (MRI)
11.1.4 Computed Tomography (CT)
11.1.5 Angiography (including Transesophageal Echocardiography)
11.1.6 Nuclear Imaging
11.1.7 Others
11.2 Middle East and Africa Structural Heart Imaging Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Valvular Heart Disease
11.2.3 Congenital Heart Disease
11.2.4 Cardiomyopathy
11.2.5 Others
11.3 Middle East and Africa Structural Heart Imaging Market (2018-2034) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 General Electric Company (GE Healthcare)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Siemens Healthineers AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Koninklijke Philips N.V.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Canon Medical Systems Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hitachi, Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shimadzu Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Esaote S.p.A.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 FUJIFILM Holdings Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Samsung Medison Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Carestream Health, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Toshiba Corporation (Canon Medical Systems)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ESAOTE SPA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Mindray Medical International Limited
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Pie Medical Imaging
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging)
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Structural Heart Imaging Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • General Electric Company (GE Healthcare)
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Hitachi, Ltd.
  • Shimadzu Corporation
  • Esaote S.p.A.
  • FUJIFILM Holdings Corporation
  • Samsung Medison Co., Ltd.
  • Carestream Health, Inc.
  • Toshiba Corporation (Canon Medical Systems)
  • ESAOTE SPA
  • Mindray Medical International Limited
  • Pie Medical Imaging
  • 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging)